These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29804492)

  • 1. Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
    Yokoe I; Kobayashi H; Kobayashi Y; Giles JT; Yoneyama K; Kitamura N; Takei M
    Scand J Rheumatol; 2018 Sep; 47(5):364-370. PubMed ID: 29804492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.
    Welsh P; Tuckwell K; McInnes IB; Sattar N
    Atherosclerosis; 2016 Nov; 254():167-171. PubMed ID: 27744141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
    Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
    Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
    Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.
    Zoli A; Bosello S; Comerci G; Galiano N; Forni A; Loperfido F; Ferraccioli GF
    Rheumatol Int; 2017 Jan; 37(1):13-19. PubMed ID: 26586235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
    Provan SA; Angel K; Odegård S; Mowinckel P; Atar D; Kvien TK
    Arthritis Res Ther; 2008; 10(3):R70. PubMed ID: 18573197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of noninvasive positive pressure ventilation treatment on plasma concentration of amino terminal-pro brain natriuretic peptide in congestive heart failure in patients with sleep apnea].
    Zhao ZH; Liu ZH; Luo Q; Zhang J; Xiong CM; Ni XH; Zhang S; Yang YJ; Ma XP
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):386-8. PubMed ID: 16780741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure.
    Täger T; Wiedergruen AK; Fröhlich H; Cebola R; Corletto A; Horsch A; Hess G; Slottje K; Zdunek D; Katus HA; Wians FH; Frankenstein L
    J Card Fail; 2017 Dec; 23(12):835-842. PubMed ID: 28757153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
    Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.